New Force in Vaccine National Team: NHRI Spin-off 'TaiU' Completes US$2M Seed Round Led by MVL Seed Fund

Taiwan Universe BioMedicine (TaiU), a startup spun off from the National Health Research Institutes (NHRI), has completed a NT$60 million (approximately US$2 million) seed funding round led by Mosaic Seed Fund, with matching investment from the National Development Fund. The funds will accelerate development of its bivalent enterovirus vaccine and seasonal influenza VLP vaccine toward clinical trials, with plans to submit an IND application in 2026 and list on the emerging stock market in 2028.